十年体检不识癌，爱康国宾的“健康防线”失守之谜

Core Viewpoint - The incident involving Zhang Xiaoling has brought significant scrutiny to Aikang Guobin, highlighting potential issues of negligence and malpractice in the health check industry, particularly regarding cancer detection and patient care [1][2]. Company Summary - Zhang Xiaoling underwent health checks at Aikang Guobin for 10 years without any indication of cancer risk, only to be diagnosed with advanced kidney cancer after switching providers [1]. - Aikang Guobin has faced allegations of false reporting and negligence, with Zhang Xiaoling sending a legal notice and a complaint to health authorities regarding potential missed diagnoses [2]. - The company has seen multiple branch closures, with many locations being deregistered, indicating operational challenges and a declining market presence [5][8]. - Financially, Aikang Guobin has struggled, with significant drops in net profit from 2015 to 2018, and estimates suggest a slow revenue growth of around 30 billion yuan in 2023, significantly lagging behind competitors [7][8]. Industry Summary - The health check industry has been expanding rapidly, but it is plagued by issues such as false advertising and unqualified personnel conducting medical procedures, which threaten the accuracy of health assessments [3][4]. - There is a notable lack of trust in the industry, with numerous complaints about inaccurate reports and misdiagnoses, as evidenced by over 1,220 complaints against Aikang Guobin on consumer platforms [8]. - The competitive landscape is challenging, with Aikang Guobin's market share significantly trailing behind major competitors like Meinian Health, which has a much larger operational footprint and customer base [6][8].